Global and United States Radioligand Therapy Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 Radioligand Therapy Revenue in Radioligand Therapy Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global Radioligand Therapy Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global Radioligand Therapy Market Size for the Year 2017-2028
  • 1.2.2 Global Radioligand Therapy Market Size for the Year 2017-2028
• 1.3 Radioligand Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.3.1 The Market Share of United States Radioligand Therapy in Global, 2017 VS 2022 VS 2028
  • 1.3.2 The Growth Rate of Radioligand Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.4 Radioligand Therapy Market Dynamics
  • 1.4.1 Radioligand Therapy Industry Trends
  • 1.4.2 Radioligand Therapy Market Drivers
  • 1.4.3 Radioligand Therapy Market Challenges
  • 1.4.4 Radioligand Therapy Market Restraints
• 1.5 Study Objectives
• 1.6 Years Considered

2 Radioligand Therapy by Used Radionuclides

• 2.1 Radioligand Therapy Market Segment by Used Radionuclides
  • 2.1.1 Actinium 225 (Ac-225)
  • 2.1.2 Lutetium 177 (Lu-177)
  • 2.1.3 Gallium 68 (Ga-68)
  • 2.1.4 Fluorine 18 (F-18)
  • 2.1.5 Other Radionuclides
• 2.2 Global Radioligand Therapy Market Size by Used Radionuclides (2017, 2022 & 2028)
• 2.3 Global Radioligand Therapy Market Size by Used Radionuclides (2017-2028)
• 2.4 United States Radioligand Therapy Market Size by Used Radionuclides (2017, 2022 & 2028)
• 2.5 United States Radioligand Therapy Market Size by Used Radionuclides (2017-2028)

3 Radioligand Therapy by Application

• 3.1 Radioligand Therapy Market Segment by Application
  • 3.1.1 Neuroendocrine Neoplasms
  • 3.1.2 Prostate Cancer
• 3.2 Global Radioligand Therapy Market Size by Application (2017, 2022 & 2028)
• 3.3 Global Radioligand Therapy Market Size by Application (2017-2028)
• 3.4 United States Radioligand Therapy Market Size by Application (2017, 2022 & 2028)
• 3.5 United States Radioligand Therapy Market Size by Application (2017-2028)

4 Global Radioligand Therapy Competitor Landscape by Company

• 4.1 Global Radioligand Therapy Market Size by Company
  • 4.1.1 Top Global Radioligand Therapy Companies Ranked by Revenue (2021)
  • 4.1.2 Global Radioligand Therapy Revenue by Player (2017-2022)
• 4.2 Global Radioligand Therapy Concentration Ratio (CR)
  • 4.2.1 Radioligand Therapy Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Companies of Radioligand Therapy in 2021
  • 4.2.3 Global Radioligand Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global Radioligand Therapy Headquarters, Revenue in Radioligand Therapy Business (2017-2022) & (US$ Million) Type
  • 4.3.1 Global Radioligand Therapy Headquarters and Area Served
  • 4.3.2 Global Radioligand Therapy Companies Revenue in Radioligand Therapy Business (2017-2022) & (US$ Million) Type
  • 4.3.3 Date of International Companies Enter into Radioligand Therapy Market
• 4.4 Companies Mergers & Acquisitions, Expansion Plans
• 4.5 United States Radioligand Therapy Market Size by Company
  • 4.5.1 Top Radioligand Therapy Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States Radioligand Therapy Revenue by Players (2020, 2021 & 2022)

5 Global Radioligand Therapy Market Size by Region

• 5.1 Global Radioligand Therapy Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Radioligand Therapy Market Size by Region (2017-2028)
  • 5.2.1 Global Radioligand Therapy Market Size by Region: 2017-2022
  • 5.2.2 Global Radioligand Therapy Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America Radioligand Therapy Market Size YoY Growth 2017-2028
  • 6.1.2 North America Radioligand Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific Radioligand Therapy Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific Radioligand Therapy Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe Radioligand Therapy Market Size YoY Growth 2017-2028
  • 6.3.2 Europe Radioligand Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America Radioligand Therapy Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America Radioligand Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa Radioligand Therapy Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa Radioligand Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 Novartis
  • 7.1.1 Novartis Company Details
  • 7.1.2 Novartis Business Overview
  • 7.1.3 Novartis Radioligand Therapy Introduction
  • 7.1.4 Novartis Revenue in Radioligand Therapy Business (2017-2022)
  • 7.1.5 Novartis Recent Development
• 7.2 Advanced Accelerator Applications
  • 7.2.1 Advanced Accelerator Applications Company Details
  • 7.2.2 Advanced Accelerator Applications Business Overview
  • 7.2.3 Advanced Accelerator Applications Radioligand Therapy Introduction
  • 7.2.4 Advanced Accelerator Applications Revenue in Radioligand Therapy Business (2017-2022)
  • 7.2.5 Advanced Accelerator Applications Recent Development
• 7.3 Mercy Radiology
  • 7.3.1 Mercy Radiology Company Details
  • 7.3.2 Mercy Radiology Business Overview
  • 7.3.3 Mercy Radiology Radioligand Therapy Introduction
  • 7.3.4 Mercy Radiology Revenue in Radioligand Therapy Business (2017-2022)
  • 7.3.5 Mercy Radiology Recent Development
• 7.4 POINT Biopharma Global Inc
  • 7.4.1 POINT Biopharma Global Inc Company Details
  • 7.4.2 POINT Biopharma Global Inc Business Overview
  • 7.4.3 POINT Biopharma Global Inc Radioligand Therapy Introduction
  • 7.4.4 POINT Biopharma Global Inc Revenue in Radioligand Therapy Business (2017-2022)
  • 7.4.5 POINT Biopharma Global Inc Recent Development
• 7.5 Fusion Pharma
  • 7.5.1 Fusion Pharma Company Details
  • 7.5.2 Fusion Pharma Business Overview
  • 7.5.3 Fusion Pharma Radioligand Therapy Introduction
  • 7.5.4 Fusion Pharma Revenue in Radioligand Therapy Business (2017-2022)
  • 7.5.5 Fusion Pharma Recent Development
• 7.6 Telix Pharmaceuticals Ltd
  • 7.6.1 Telix Pharmaceuticals Ltd Company Details
  • 7.6.2 Telix Pharmaceuticals Ltd Business Overview
  • 7.6.3 Telix Pharmaceuticals Ltd Radioligand Therapy Introduction
  • 7.6.4 Telix Pharmaceuticals Ltd Revenue in Radioligand Therapy Business (2017-2022)
  • 7.6.5 Telix Pharmaceuticals Ltd Recent Development
• 7.7 Lantheus Holdings, Inc
  • 7.7.1 Lantheus Holdings, Inc Company Details
  • 7.7.2 Lantheus Holdings, Inc Business Overview
  • 7.7.3 Lantheus Holdings, Inc Radioligand Therapy Introduction
  • 7.7.4 Lantheus Holdings, Inc Revenue in Radioligand Therapy Business (2017-2022)
  • 7.7.5 Lantheus Holdings, Inc Recent Development
• 7.8 Bayer AG
  • 7.8.1 Bayer AG Company Details
  • 7.8.2 Bayer AG Business Overview
  • 7.8.3 Bayer AG Radioligand Therapy Introduction
  • 7.8.4 Bayer AG Revenue in Radioligand Therapy Business (2017-2022)
  • 7.8.5 Bayer AG Recent Development
• 7.9 Curium Pharma
  • 7.9.1 Curium Pharma Company Details
  • 7.9.2 Curium Pharma Business Overview
  • 7.9.3 Curium Pharma Radioligand Therapy Introduction
  • 7.9.4 Curium Pharma Revenue in Radioligand Therapy Business (2017-2022)
  • 7.9.5 Curium Pharma Recent Development
• 7.10 Precirix
  • 7.10.1 Precirix Company Details
  • 7.10.2 Precirix Business Overview
  • 7.10.3 Precirix Radioligand Therapy Introduction
  • 7.10.4 Precirix Revenue in Radioligand Therapy Business (2017-2022)
  • 7.10.5 Precirix Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
  • 9.1.1 Methodology/Research Approach
  • 9.1.2 Data Source
• 9.2 Author Details